CYP2B6 抗体
(Cytochrome P450, Family 2, Subfamily B, Polypeptide 6 (CYP2B6))
This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described\; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| CYP2B6 抗体 (AA 401-491) (Cy5.5) | 人 | 兔 Polyclonal |
|
|
|
| CYP2B6 抗体 (AA 401-491) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| CYP2B6 抗体 (AA 401-491) (Cy3) | 人 | 兔 Polyclonal |
|
|
|
| CYP2B6 抗体 (Internal Region) | 人 | 兔 Polyclonal |
|
|
|
| CYP2B6 抗体 (AA 235-263) (PE) | 人 | 兔 Polyclonal |
|
|
|
| CYP2B6 抗体 (AA 235-263) (APC) | 人 | 兔 Polyclonal |
|
|
|
| CYP2B6 抗体 (AA 235-263) | 人 | 兔 Polyclonal |
|
|
|
| CYP2B6 抗体 (AA 235-263) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| CYP2B6 抗体 (AA 235-263) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| CYP2B6 抗体 (AA 235-263) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| CYP2B6 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| CYP2B6 抗体 (AA 250-343) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| CYP2B6 抗体 (AA 250-343) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| CYP2B6 抗体 (AA 250-343) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| CYP2B6 抗体 (AA 210-290) | 人 | 兔 Polyclonal |
|
|
|
| CYP2B6 抗体 (Center) | 人 | 兔 Polyclonal |
|
|
|
| CYP2B6 抗体 (His271) | 人 | 兔 Polyclonal |
|
|
|
| CYP2B6 抗体 (AA 247-259) | 人 | 山羊 Polyclonal |
|
|
|
| CYP2B6 抗体 (AA 462-488) | 人 | 兔 Polyclonal |
|
|
|
| CYP2B6 抗体 (Middle Region) | 人, 小鼠, 大鼠, 犬, Cow, 豚鼠, 马, 兔 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5.5
- 抗体亚型
- IgG
- 抗原表位
- AA 401-491
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 401-491
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- 抗原表位
- AA 401-491
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Internal Region
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 235-263
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 235-263
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 235-263
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 235-263
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 235-263
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 235-263
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 3D5
- 标记
- unconjugated
- 抗体亚型
- IgG2a
Primary Antibody
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 250-343
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 250-343
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 250-343
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 210-290
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Center
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- His271
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 质量等级
- Verified
- 适用
- 人
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 247-259
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 462-488
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 小鼠, 大鼠, 犬, Cow, 豚鼠, 马, 兔
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Middle Region
Latest Publications for our CYP2B6 抗体
: "Xenobiotic Nuclear Receptor Signaling Determines Molecular Pathogenesis of Progressive Familial Intrahepatic Cholestasis." in: Endocrinology, Vol. 159, Issue 6, pp. 2435-2446, (2019) (PubMed).
: "Characterization of feline cytochrome P450 2B6." in: Xenobiotica; the fate of foreign compounds in biological systems, Vol. 47, Issue 2, pp. 93-102, (2017) (PubMed).
: "Selective induction of hepatic cytochrome P450 2B activity by leelamine in vivo, as a potent novel inducer." in: Archives of pharmacal research, Vol. 38, Issue 5, pp. 725-33, (2015) (PubMed).
: "Hepatic expression of detoxification enzymes is decreased in human obstructive cholestasis due to gallstone biliary obstruction." in: PLoS ONE, Vol. 10, Issue 3, pp. e0120055, (2015) (PubMed).
: "Combination therapy of cyclophosphamide and Rhizoma Paridis Saponins on anti-hepatocarcinoma mice and effects on cytochrome p450 enzyme expression." in: Steroids, Vol. 80, pp. 1-6, (2014) (PubMed).
: "The role of cytochromes p450 and aldo-keto reductases in prognosis of breast carcinoma patients." in: Medicine, Vol. 93, Issue 28, pp. e255, (2014) (PubMed).
: "Self-limited versus delayed resolution of acute inflammation: temporal regulation of pro-resolving mediators and microRNA." in: Scientific reports, Vol. 2, pp. 639, (2012) (PubMed).
: "Characterization of feline cytochrome P450 2B6." in: Xenobiotica; the fate of foreign compounds in biological systems, Vol. 47, Issue 2, pp. 93-102, (2017) (PubMed).
: "Selective induction of hepatic cytochrome P450 2B activity by leelamine in vivo, as a potent novel inducer." in: Archives of pharmacal research, Vol. 38, Issue 5, pp. 725-33, (2015) (PubMed).
: "Hepatic expression of detoxification enzymes is decreased in human obstructive cholestasis due to gallstone biliary obstruction." in: PLoS ONE, Vol. 10, Issue 3, pp. e0120055, (2015) (PubMed).
: "Combination therapy of cyclophosphamide and Rhizoma Paridis Saponins on anti-hepatocarcinoma mice and effects on cytochrome p450 enzyme expression." in: Steroids, Vol. 80, pp. 1-6, (2014) (PubMed).
: "The role of cytochromes p450 and aldo-keto reductases in prognosis of breast carcinoma patients." in: Medicine, Vol. 93, Issue 28, pp. e255, (2014) (PubMed).
: "Self-limited versus delayed resolution of acute inflammation: temporal regulation of pro-resolving mediators and microRNA." in: Scientific reports, Vol. 2, pp. 639, (2012) (PubMed).
Aliases for CYP2B6 抗体
cytochrome P450 family 2 subfamily B member 6 (CYP2B6) 抗体cytochrome P450 family 4 subfamily F member 3 (CYP4F3) 抗体
cytochrome P450, family 2, subfamily B, polypeptide 6 (CYP2B6) 抗体
cytochrome P450 family 2 subfamily B member 6 L homeolog (cyp2b6.L) 抗体
cytochrome P450 2B11 (CYP2B6) 抗体
cytochrome P450, family 21, subfamily a, polypeptide 1 (Cyp21a1) 抗体
cytochrome P450 subfamily 2B (CYP2B6) 抗体
cytochrome P450 2B11-like (LOC100068603) 抗体
21-OH 抗体
21OH 抗体
21OHA 抗体
21OHB 抗体
CPB6 抗体
CPF3 抗体
CYP2B 抗体
CYP2B6 抗体
CYP2B7 抗体
CYP2B7P 抗体
CYP2B11 抗体
CYP2B30 抗体
CYP4F 抗体
Cyp21 抗体
Cyp21-ps1 抗体
Cyp21a2-ps 抗体
Cyp21a2ps 抗体
Cyp21B 抗体
CYP21OH-A 抗体
CYPIIB6 抗体
CYPIIB11 抗体
EFVM 抗体
IIB1 抗体
LTB4H 抗体
Oh21-1 抗体
Oh21-2 抗体
P450 抗体
您还需要查找其他产品吗？
You are here:
